Cardiome Pharma Corp. (T:COM)

Business Focus: Biopharmaceuticals

This company is also listed in the United States as CRME on the NASDAQ. Click here to see if there are any SEC insider filings on insidertracking.com.
Log in or sign up for a free account to add this stock to your watch list.

Insider Chart - Past 6 Months


Insider Filings

Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by transaction date) for COM within the last 6 months ?
Amended Filing
As of 11:59pm ET August 28th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 12/15 Jun 22/15 Dean, David Cameron Peter Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report    
Aug 12/15 Jun 22/15 Dean, David Cameron Peter Direct Ownership Options 00 - Opening Balance-Initial SEDI Report 50,000  
Jul 14/15 Jun 22/15 O'Shea, William James Direct Ownership Options 50 - Grant of options 4,000 $11.66
Jun 29/15 Jun 22/15 Willms, Arthur Henry Direct Ownership Options 00 - Opening Balance-Initial SEDI Report 14,000  
Jun 26/15 Jun 22/15 Shlevin, Harold Direct Ownership Options 50 - Grant of options 10,000 $11.66
Jun 26/15 Jun 22/15 O'Shea, William James Direct Ownership Options 50 - Grant of options 10,000 $11.66
Jun 26/15 Jun 22/15 Glickman, Richard Direct Ownership Options 50 - Grant of options 10,000 $11.66
Jun 26/15 Jun 22/15 Corrigan, Mark Direct Ownership Options 50 - Grant of options 14,000 $11.66
Jun 26/15 Jun 22/15 Corrigan, Mark Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
Jun 4/15 Jun 2/15 Archibald, Jennifer Direct Ownership Options 52 - Expiration of options -200 $43.20
Cardiome Pharma Corp. Insider Report Only $20.00